Nephrotic Syndrome Diagnostics & Therapeutics Market Size & Growth Analysis Report, 2021-2027
The global nephrotic syndrome diagnostics & therapeutics market is anticipated to grow at a CAGR of around 5.6% during the forecast period (2021-2027). The key factor to drive the market growth includesthe increasing prevalence of diabetes that results in increased chances of nephrotic syndrome. For instance, In the European Union, approximately 32.3 million adults were diagnosed with diabetes in 2019, up from an estimated 16.8 million adults in 2000. In 2019, it was estimated that around 24.2 million people in Europe will be having diabetes but will go undiagnosed.Since 2000, the number of men diagnosed with diabetes has more than doubled, rising from about 7.3 million in 2000 to 16.7 million in 2019. Women with diabetes have also increased significantly, from 9.5 million in 2000 to 15.6 million in 2019.
To Request a Sample of our Report on Nephrotic Syndrome Diagnostics & Therapeutics Market: https://www.omrglobal.com/request-sample/nephrotic-syndrome-diagnostics-therapeutics-market
Rising acquisitions, product approval, collaborations among the
major players in the market also propel the growth of the market. For instance,
in April 2019, Angion announced a partnership agreement with Nephrotic Syndrome
Study Network (NEPTUNE)in order to investigate ANG-3070. This clinical research
is based on understanding and treatment of kidney disorders.These findings of
the research will supportdetermining the inclusion requirements for a biomarker
stratified prospective clinical trial evaluating the safety and efficacy of
ANG-3070 in primary Focal segmental glomerulosclerosis (FSGS) patients,
ensuring that the most likely patients benefit from treatment.
A full Report of Nephrotic Syndrome Diagnostics &
Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/nephrotic-syndrome-diagnostics-therapeutics-market
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Diagnosis Test
·
By Treatment
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
·
Competitive Landscape-
·
Urinalysis
·
Blood
Tests
·
Kidney
Biopsy
·
Others
(CT Scan, Renal Ultra-Sonography)
By Treatment
·
Blood
Pressure Lowering Medications
·
Angiotensin-Converting
Enzyme (ACE) Inhibitors
·
Angiotensin
Receptor Blockers (ARBs)
·
Others
(Renin Inhibitors and Benazepril)
·
Immune
System-Suppressing Medications
·
Cholesterol-Reducing
Medications
·
Others
(Blood Thinners)
Regional Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest oF APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company Profiles
·
Abbott
Laboratories
·
Asahi
Kasei Pharma Corp.
·
AstraZeneca
PLC
·
Aurinia
Pharmaceuticals Inc.
·
Bristol-Myers
Squibb Co.
·
DaVita
Inc.
·
Eli
Lilly and Co.
·
GeneDx
Inc.
·
GlaxoSmithKline
PLC
·
Johnson
and Johnson Services Inc.
·
Mallinckrodt
LLC
·
Novartis
International AG
·
Pfizer
Inc.
·
Sanofi
SA
·
ZyVersa
Therapeutics, Inc.
Reasons
to Buying From us –
1. We cover more than 15 major industries,
further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for
investigation.
4. Our expert research analysts answer all your
questions before and after purchasing your report.
For More Customized Data, Request for Report
Customization @ https://www.omrglobal.com/report-customization/nephrotic-syndrome-diagnostics-therapeutics-market
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
For More
Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment